)
Edge1 May 2026
Making the Marlboro Man
The story of Marlboro's transformation from a women's cigarette to a global icon: one of the most effective brand repositionings in history.
Dicot
Dicot (DICOT) investor relations material
Dicot Q1 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q1 2026 earnings summary30 Apr, 2026
Executive summary
Focused on advancing LIB-01, a novel erectile dysfunction drug, with preparations for a phase 2b study in the US and Europe set for the second half of 2026.
Successfully developed a tablet formulation of LIB-01 and began manufacturing for clinical trials.
Announced a planned rights issue of SEK 210 million, 80% secured, to fully fund the phase 2b study.
Strong institutional and investor interest, with participation in major industry conferences.
Financial highlights
Net sales were SEK 0.0 million for the quarter, unchanged year-over-year.
Result after financial items was SEK -14.8 million, improved from SEK -22.9 million in Q1 2025.
Earnings per share remained at SEK -0.01, unchanged from the same quarter last year.
Operating expenses decreased to SEK 15.1 million from SEK 23.6 million year-over-year.
Cash and cash equivalents at quarter-end were SEK 56.2 million, down from SEK 92.8 million a year earlier.
Outlook and guidance
Phase 2b clinical trial for LIB-01 planned to start in the second half of 2026 in the US and Europe.
Rights issue of SEK 210 million, 80% secured, will provide full funding for the phase 2b study.
Continued focus on out-licensing and industrial partnerships to support future phase 3 financing.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Dicot
- LIB-01's phase 2a success drives clinical progress, but further funding is needed for phase 2b.DICOT
Q4 202518 Feb 2026 - LIB-01's Phase 2a success and strong cash position set the stage for next clinical milestones.DICOTQ3 202523 Oct 2025
- Phase 2a study enrollment completed; strong cash position supports next development steps.DICOTQ2 202512 Aug 2025
- LIB-01 phase 2a trial fully funded after oversubscribed rights issue; Nasdaq listing approved.DICOTQ3 202413 Jun 2025
- Phase 2a for LIB-01 is fully funded after a 65%-secured SEK 122.6M rights issue.DICOTQ2 202413 Jun 2025
- Strong warrant uptake and robust cash position support ongoing LIB-01 clinical progress.DICOTQ1 20256 Jun 2025
- LIB-01 advanced to phase 2a with robust funding and new US patents, positioning for growth.DICOTQ4 20245 Jun 2025
Next Dicot earnings date
Q2 202620 Aug, 2026
Dicot
Next Dicot earnings date
Q2 202620 Aug, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage